Exploring how cellular identity orchestrates a dynamic network of proteins around KRASG12C, dictating treatment success or failure in cancer therapy.
Groundbreaking research reveals how rhabdomyosarcoma cancer cells with lower PAX3:FOXO1 oncogene expression can be more aggressive and tumorigenic than high-expressing cells.
Discover how gamma-tubules, the newly discovered cellular filaments, are revolutionizing cancer treatment by targeting tumors selectively while sparing healthy cells.
Exploring the revolutionary next-generation microtubule-targeting agents that are transforming cancer treatment paradigms.
Discover how cells regulate energy production through spatial and temporal organization of metabolic pathways in cancer and yeast cells.